Prevalence and Risk Factors for Financial Toxicity Among Sarcoma Patients During and Following Treatment Across the Lifespan
ABSTRACT Background Financial toxicity (FT) describes the impact of cancer and treatment‐related financial burden. We evaluated the prevalence and risk factors for FT among sarcoma patients. Methods A sarcoma cohort was constructed to assess health outcomes. FT was measured via “COmprehensive Score for financial Toxici...